The sensitivity and specificity of the 9-item Wearing-off Questionnaire

Parkinsonism and Related Disorders

Volumn 14, Issue 3, 2008, Pages 205-212

  Stacy, M A ^a   Murphy, J M ^b   Greeley, D R ^c   Stewart, R M ^d   Murck, H ^e   Meng, X ^e  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Associated Neurologists   (United States)

^c PLLC   (United States)

^d Folgelson Neuroscience Center   (United States)

^e NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Motor fluctuations; Motor symptoms; Non motor symptoms; Parkinson's disease; Patient questionnaire; Wearing off

Indexed keywords

AMANTADINE; APOMORPHINE; BENZATROPINE MESILATE; BROMOCRIPTINE MESILATE; CARBEX; CARBIDOPA PLUS ENTACAPONE PLUS LEVODOPA; CARBIDOPA PLUS LEVODOPA; ENTACAPONE; PERGOLIDE MESILATE; PRAMIPEXOLE; ROPINIROLE; SELEGILINE; TOLCAPONE; TRIHEXYPHENIDYL;

AGED; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; PARKINSON DISEASE; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; QUESTIONNAIRE; SCREENING TEST; SYMPTOM; TREATMENT OUTCOME; WEARING OFF; WEARING OFF QUESTIONNAIRE;

AGED; ANTIPARKINSON AGENTS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; DRUG RESISTANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PARKINSON DISEASE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 41449108899     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2007.07.013     Document Type: Article

References (11)

1. Marsden C.D., and Parkes J.D. Success and problems of long-term levodopa therapy in parkinson's disease. Lancet 1 (1977) 345-349
2. Parkinson study group. pramipexole vs levodopa as initial treatment for parkinson disease: a randomized controlled trial. J Am Med Assoc 284 (2000) 1931-1938
3. Parkinson Study Group. Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Parkinson study group. Ann Neurol 39 (1996) 37-45
4. Obeso J.A., Olanow C.W., and Nutt J.G. Levodopa motor complications in Parkinson's disease. Trends Neurosci 23 Suppl (2000) S2-S7
5. Olanow C.W., Agid Y., Mizuno Y., Albanese A., Bonucelli U., Damier P., et al. Levodopa in the treatment of Parkinson's disease: current controversies. Mov Disord 19 (2004) 997-1005
6. Swope D.M. Rapid treatment of "wearing off" in Parkinson's disease. Neurology 62 Suppl (2004) S27-S31
7. Stacy M., Bowron A., Guttman M., Hauser R., Hughes K., Larsen J.P., et al. Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment. Mov Disord 20 (2005) 726-733
8. Stacy M. An abbreviated wearing-off patient questionnaire (WOPQ): sensitivity analysis. In: Poster presented at the ninth international congress of Parkinson's disease and movement disorders, 5-8 March 2005; New Orleans, Louisiana.
9. Stacy M., Hauser R., Oertel W., Schapira A., Sethi K., Stocchi F., et al. End-of-dose wearing off in Parkinson disease: a 9-question survey assessment. Clin Neuropharmacol 29 (2006) 312-321
10. Azulay JP, Durif F, Rogez R, Tranchant C, Bourdeix I, Rerat K. PRECOCE survey: a new self-assessment patient card for early detection and management of parkinson's disease fluctuations. In: Poster presented at: 16th international congress on Parkinson's disease and related disorders, 5-9 June 2005; Berlin, Germany.
11. Witjas T., Kaphan E., Azulay J.P., Blin O., Ceccaldi M., Pouget J., et al. Nonmotor fluctuations in Parkinson's disease: frequent and disabling. Neurology 59 (2002) 408-413